Neuroprotection for ischaemic stroke: an unattainable goal?
about
Inflammation and infection in clinical strokeHyperoxic reperfusion after global cerebral ischemia promotes inflammation and long-term hippocampal neuronal deathTargeting NOX enzymes in the central nervous system: therapeutic opportunities.Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies.Regulation of microglia - potential new drug targets in the CNS.The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?Pharmacological modulation of plasticity in the human motor cortex.Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic moleculesTransient Oxygen/Glucose Deprivation Causes a Delayed Loss of Mitochondria and Increases Spontaneous Calcium Signaling in Astrocytic Processes.Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks.Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic strokeDe-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.CeeTox™ Analysis of CNB-001 a Novel Curcumin-Based Neurotrophic/Neuroprotective Lead Compound to Treat Stroke: Comparison with NXY-059 and Radicut.AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils.Microvascular Basal lamina damage after embolic stroke in the rat: relationship to cerebral blood flow.Induction of the Wnt antagonist, Dickkopf-1, contributes to the development of neuronal death in models of brain focal ischemia.
P2860
Q28194382-EE7745DC-FD6E-408C-8991-8CE054004510Q33841247-AA56852E-1CF2-4B2F-9A64-658D28458B59Q34285497-4C2C38D6-7FFE-41ED-B22F-0BFC4D46269DQ34339866-9EF7ABFD-213B-4D8A-8F1A-210D7BAC64CAQ35050412-AD9C0593-CAB5-4B0E-80B9-C37F7EE5FA9AQ35842504-FB53FB06-24D9-40F3-9449-1F8CBFCB2E8AQ36470509-FC1B6723-445B-42F8-8BA8-91B6AE741C6AQ36841904-CDC98614-84D4-463D-8FF1-606A690F6DC6Q37080014-AB231811-BAC7-4AC0-A64C-13A7EE220A7AQ37420266-07E61EB6-E10C-4DA4-AAE3-8ACCAF210178Q37873970-31F6C8A1-F4A2-46A3-9C13-766D5E89AA5EQ38262540-9AC87732-9B1D-4C39-9A56-ECCFC43F0D2FQ38681976-A5843AF2-2AF4-4C14-A560-6E1F469BADA7Q39558507-82AE5CEB-3699-446F-B605-0242C2F619C2Q42952149-8F54A7BD-EE23-4171-8DCB-DCFCE931C3D6Q48153524-6A98C806-C529-42B5-9385-12C5510BD858Q48900276-5989ACD2-313B-4643-B83B-FA09EE243118
P2860
Neuroprotection for ischaemic stroke: an unattainable goal?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuroprotection for ischaemic stroke: an unattainable goal?
@ast
Neuroprotection for ischaemic stroke: an unattainable goal?
@en
Neuroprotection for ischaemic stroke: an unattainable goal?
@nl
type
label
Neuroprotection for ischaemic stroke: an unattainable goal?
@ast
Neuroprotection for ischaemic stroke: an unattainable goal?
@en
Neuroprotection for ischaemic stroke: an unattainable goal?
@nl
prefLabel
Neuroprotection for ischaemic stroke: an unattainable goal?
@ast
Neuroprotection for ischaemic stroke: an unattainable goal?
@en
Neuroprotection for ischaemic stroke: an unattainable goal?
@nl
P1433
P1476
Neuroprotection for ischaemic stroke: an unattainable goal?
@en
P2093
Liebeskind DS
P304
P356
10.2165/00023210-200115030-00001
P577
2001-01-01T00:00:00Z
P6179
1033972382